GFAP and acrodermatitis enteropathica: However, treatment with corticosteroids or rituximab—administered alone or in combination—was associated with lower levels of T and B cell infiltration, GPNMB+ phagocytes, and GFAP+C3+ neurotoxic astrocytes in IC-AE (Fig. S5f).